European Cystic Fibrosis Society

Abstract submissions are invited for the 33rd European Cystic Fibrosis Conference.  They form an important part of the conference, and accepted abstracts will be published in a supplement to the Journal of Cystic Fibrosis.

Abstract Submission Deadline: 22 January 2010

The online Abstract submission system is closed.

General Instructions

• Abstracts must be submitted in English.
• Submissions from all fields of CF are welcome; however abstracts related to the Workshop topics of the Conference are particularly encouraged.
• Do not submit abstracts reporting data already published.
• Abstracts should be as informative as possible and should adequately describe the objectives, methods, and conclusions of the research.
• Case reports are strongly discouraged.  Case Presentations in specific categories may be submitted via a second submission system - please refer to the separate link dealing with Case Presentations.
• Posters are particularly suitable for presentation of complex data or material requiring extensive illustration. It should be noted that poster presentations carry the same status as oral presentations and will be subjected to the same selection process.
• All accepted abstracts are to be presented in poster form.  A limited number of accepted abstracts will also be selected by the Scientific Committee for oral presentation in the workshops.  Instructions for poster and oral presentation will be included in the abstract notification to corresponding authors after the review process.

Preference will be given to new and/or ongoing work.

Abstracts are to be submitted using the electronic on-line system – no other submission medium may be used.

As part of the on-line submission process, corresponding authors are responsible for:

• Ensuring that all authors of a submitted abstract have agreed to have the abstract submitted and published, if accepted.
• Acknowledging that the contents of the abstract have not been published prior to the date of submission.
• Understanding that accepted abstracts will be published in a supplement to the Journal of Cystic Fibrosis.  Publication is scheduled for June 2010.
• Completing a Conflict of Interest Disclosure Statement: A conflict of interest is defined as the existence of any significant financial interest or other relationship with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. Corresponding authors will need to indicate whether or not there is a conflict of interest relative to their submitted abstract.

Other Instructions:

• Abstracts should not contain proprietary or confidential information.
• The presenting author of an accepted abstract must register for the Conference.

Available Categories for Abstracts

Pulmonology
New therapies
Gastroenterology / Liver
Nutrition / Growth
Genetics
Screening & Diagnosis
Microbiology
- Antibiotics (Optional sub-category of Microbiology from a drop down menu online)
- Pathogenesis (Optional sub-category of Microbiology from a drop down menu online)
- Diagnosis and Epidemiology (Optional sub-category of Microbiology from a drop down menu online)
Immunology / Inflammation
Metabolic complications of CF
Cell Biology / Physiology
CFTR
Nursing
Physiotherapy
Psychosocial Issues
Epidemiology / Registry
Other Issues

Online Abstract Submission

The electronic submission and review process has been designed to ensure that no one other than authorised reviewers and the ECFS Administration will have access to abstracts before the publication date. 
 
Each step of the online abstract submission process is accompanied with instructions.  Please read these carefully as you navigate through the different steps.

• Corresponding Author:  Corresponding authors are required to create a user account prior to submitting an abstract.  Thereafter a user name and password will be used for entering the system.
• Maximum Characters: Abstract title, author details, affiliations, and abstract body may be no longer than 2,000 characters, including spaces.  The electronic system allows for the submission of tables, however please be aware that each row of a table will deduct 50 characters from the total available for your abstract.  Images are not to be included but graphs, photos, etc. may be displayed on the corresponding poster.
• Abstract Titles should be in Title Case: This Title Is Written In Title Case.
• Authors: Authors’ names are to be entered with a first name and second name and corresponding affiliation. The system will automatically select the initial of the First Name and add a comma between names if there is more than one author.  The system will also automatically add a subscript reference to the appropriate affiliation.
• Affiliations:  The system will automatically add a subscript reference to the appropriate author.
• Spacing: The abstract body is to be single line spaced.
• Abbreviations: Standard abbreviations are acceptable. Any special abbreviations should be given in parenthesis after the first appearance of the full word or phrase for which it stands.
• Young Investigator Award: At Step 4 of the abstract submission process, young investigators (under the age of 35) have the opportunity of applying for an award. 

Young investigators under the age of 35 are eligible to be considered for an award recognizing the research work contained in their abstract submission.  The award scheme is applicable for all the abstract categories.  The Scientific Committee of the 33rd ECFS Conference will, as part of the abstract review process, select the abstracts they deem most worthy of this award.
All applications for the award are required to be supported by a letter from the Head of Department which can be submitted to the ECFS office by fax or email.  The letter should confirm the Applicant's name, Date of Birth, Institution and Department, and include the title of the abstract being submitted.  Head of Department letters are to be sent to the ECFS Office no later than 23 January 2010 by Fax: +45 86 676290 or by Email (in PDF) to: . 

The award recipients will be notified after the review process and will be acknowledged during the conference.

Revisions to abstracts after the submission deadline (22 January 2010 23:59:59 Central European Time) will not be permitted.  Please proof read your abstract carefully before submitting it.

Only completed, submitted abstracts will be eligible for review.  Abstracts remaining in the system as “drafts” after the submission deadline will be discarded.  An international team appointed by the 33rd ECFS Scientific Committee will review the abstracts.  The decision of the 33rd ECFS Scientific Committee is final.
 
Requests for the withdrawal of an abstract must be received in writing by the ECFS before 1st April 2010.